An open-label pilot study of the combination therapy of metformin and fluoxetine for weight reduction

被引：0
|
作者：
M Siavash Dastjerdi
F Kazemi
A Najafian
M Mohammady
A Aminorroaya
M Amini
机构：
[1] Isfahan University of Medical Sciences,Department of Internal Medicine
[2] Isfahan Endocrine & Metabolism Research Center,Department of Internal Medicine
[3] Sedigheh Tahereh Medical Research Complex,undefined
[4] Isfahan University of Medical Sciences,undefined
来源：
International Journal of Obesity | 2007年 / 31卷
关键词：
fluoxetine; metformin; weight reduction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：713 / 717
页数：4
相关论文
共 50 条
  • [41] An Open-Label Phase I Study of Metformin and Nelfinavir in Combination With Bortezomib in Patients With Relapsed and Refractory Multiple Myeloma
    Alodhaibi, Ibrahim
    Ailawadhi, Sikander
    Burbano, Gabriel P.
    O'Brien, Patrick J.
    Buadi, Francis K.
    Hayman, Suzanne
    Kumar, Shaji K.
    Gonsalves, Wilson I.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (05): : 298 - 304
  • [42] Use of fluoxetine for treatment of Machado-Joseph disease: an open-label study
    Monte, TL
    Rieder, CRM
    Tort, AB
    Rockenback, I
    Pereira, ML
    Silveira, I
    Ferro, A
    Sequeiros, J
    Jardim, LB
    ACTA NEUROLOGICA SCANDINAVICA, 2003, 107 (03): : 207 - 210
  • [43] Effect of metformin on olanzapine-induced weight gain: A 12-week randomised open-label study
    Kumar, G. Chetan
    Sarala, N.
    Reddy, M. Mohan
    Manjunath, H.
    JOURNAL OF CLINICAL SCIENCES, 2025, 22 (01) : 11 - 17
  • [44] Long-term antidepressant efficacy and safety of olanzapine/fluoxetine combination:: A 76-week open-label study
    Corya, SA
    Andersen, SW
    Detke, HC
    Kelly, LS
    Van Campen, LE
    Sanger, TM
    Williamson, DJ
    Dubé, S
    JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (11) : 1349 - 1356
  • [45] Efficacy and Safety of Pioglitazone versus Glimepiride after Metformin and Alogliptin Combination Therapy: A Randomized, Open-Label, Multicenter, Parallel-Controlled Study
    Kim, Jeong Mi
    Kim, Sang Soo
    Kim, Jong Ho
    Kim, Mi Kyung
    Kim, Tae Nyun
    Lee, Soon Hee
    Lee, Chang Won
    Park, Ja Young
    Kim, Eun Sook
    Lee, Kwang Jae
    Choi, Young Sik
    Kim, Duk Kyu
    Kim, In Joo
    DIABETES & METABOLISM JOURNAL, 2020, 44 (01) : 67 - 77
  • [46] Immunoadsorption patients with multiple sclerosis:: an open-label pilot study
    Moldenhauer, A
    Haas, J
    Wäscher, C
    Derfuss, T
    Hoffmann, KT
    Kiesewetter, H
    Salama, A
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2005, 35 (08) : 523 - 530
  • [47] Open-label pilot study of quetiapine treatment for cannabis dependence
    Mariani, John J.
    Pavlicova, Martina
    Mamczur, Agnieszka K.
    Bisaga, Adam
    Nunes, Edward V.
    Levin, Frances R.
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2014, 40 (04): : 280 - 284
  • [48] COGNITIVE REFOCUSING TREATMENT FOR INSOMNIA: AN OPEN-LABEL PILOT STUDY
    Gellis, L. A.
    SLEEP, 2009, 32 : A260 - A260
  • [49] Open-label pilot study of lisdexamfetamine for cocaine use disorder
    Mariani, John J.
    Choi, C. Jean
    Pavlicova, Martina
    Mahony, Amy L.
    Brooks, Daniel J.
    Grabowski, John
    Levin, Frances R.
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2021, 47 (03): : 402 - 409
  • [50] Mycophenolate mofetil for myasthenia gravis: An open-label pilot study
    Ciafaloni, E
    Massey, JM
    Tucker-Lipscomb, B
    Sanders, DB
    NEUROLOGY, 2001, 56 (01) : 97 - 99
12345